Genmab A/S

Genmab A/S Cash Flow per Share

The Operating Cash Flow per Share of Genmab A/S (GMAB.CO) as of Oct 12, 2026 is 2.81 USD. In the previous year, Operating Cash Flow per Share was 18.65 USD — a change of -84.94% (lower).

Cash Flow per Share

2.81USD

YoY

-84.94%

Last updated:

Operating Cash Flow per Share of Genmab A/S is 2025 2.81 USD. Operating Cash Flow per Share of Genmab A/S was 2024 18.65 USD. It decreases by -84.94% lower compared to the previous year.

The Genmab A/S Cash Flow per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
2.54 USD
Jan 1, 2019
3.18 USD
Jan 1, 2020
15.15 USD
Jan 1, 2021
5.23 USD
Jan 1, 2022
9.08 USD
Jan 1, 2023
17.13 USD
Jan 1, 2024
18.65 USD
Jan 1, 2025
2.81 USD
The Genmab A/S Cash Flow per Share history
YEARCash Flow per ShareYoY
2.81USD-84.94%
18.65USD+8.92%
17.13USD+88.73%
9.08USD+73.50%
5.23USD-65.47%
15.15USD+376.93%
3.18USD+25.11%
2.54USD-34.30%
3.86USD+360.77%
0.84USD+3.38%
0.81USD+125.89%
0.36USD—
Access this data via the Eulerpool API
Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Operating Cash Flow per Share of Genmab A/S is 2.81 USD in 2025.

Operating Cash Flow per Share of Genmab A/S changed from 18.65 USD to 2.81 USD, representing a -84.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow per share measures the operating cash generated per outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Genmab A/S

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Genmab A/S